TY - JOUR T1 - High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis JF - J Hepatol Y1 - 2018 A1 - Puoti, M. A1 - Foster, G.R. A1 - Wang, S A1 - et, al VL - 69 SP - 293-300 IS - 2 ER -